Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study to Investigate the Clinical Impact of EOB-MRI in the Diagnosis of Liver Metastasis of Pancreatic Cancer in Japan - A Real-World Study

NCT06106568 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06106568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06106568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study to Investigate the Clinical Impact of EOB-MRI in the Diagnosis of Liver Metastasis of Pancreatic Cancer in Japan - A Real-World Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 20, 2023
Completion date
October 30, 2024
Enrollment
39,624 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gadoxetate sodium-enhanced magnetic resonance imaging, liver metastases, metastatic pancreatic cancer